| Recruiting | Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Foca Focal Epilepsy | Phase 3 | 2026-01-29 |
| Enrolling By Invitation | Clinical Trial of Vormatrigine in Adult Patients With Epilepsy Epilepsy, Tonic-Clonic, Focal Seizure, Primary Generalized Seizure | Phase 3 | 2025-10-27 |
| Recruiting | A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety Epileptic Encephalopathy, SCN2A Encephalopathy | Phase 3 | 2025-08-13 |
| Recruiting | A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine Developmental and Epileptic Encephalopathy 1 | Phase 3 | 2025-07-09 |
| Not Yet Recruiting | A Clinical Trial to Evaluate the Relative Bioavailability of PRAX-628 Healthy | Phase 1 | 2025-03-24 |
| Recruiting | An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Focal Onset Seizure, Primary Generalized Epilepsy | Phase 2 | 2025-01-10 |
| Recruiting | Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWE Focal Seizure | Phase 2 / Phase 3 | 2024-12-11 |
| Enrolling By Invitation | Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential T Essential Tremor | Phase 3 | 2023-11-02 |
| Active Not Recruiting | A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) SCN2A Encephalopathy, SCN8A Encephalopathy | Phase 2 / Phase 3 | 2023-08-02 |
| Recruiting | A Clinical Trial of PRAX-222 in Pediatric Participants With Early Onset SCN2A Developmental and Epileptic Ence SCN2A-DEE, Epilepsy | Phase 1 / Phase 2 | 2023-04-13 |
| Completed | A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and E SCN2A-DEE, Epilepsy | — | 2022-04-15 |
| Withdrawn | A Clinical Trial of PRAX-114 in Participants With Essential Tremor Essential Tremor | Phase 2 | 2022-04-05 |
| Terminated | A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder Post-traumatic Stress Disorder, Post Traumatic Stress Disorder, Stress Disorder | Phase 2 | 2022-01-25 |
| Completed | A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor Essential Tremor | Phase 2 | 2021-10-14 |
| Completed | A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2021-06-24 |
| Completed | A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder Major Depressive Disorder | Phase 2 / Phase 3 | 2021-03-30 |
| Completed | A Clinical Trial of PRAX-944 in Participants With Essential Tremor Essential Tremor | Phase 2 | 2020-03-03 |